• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.61%

    Novo Nordisk A/S (NVO)

    -NYSE
    55.30 Down 0.43(0.78%) 1:59PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:55.73
    Open:56.15
    Bid:55.31 x 400
    Ask:55.33 x 500
    1y Target Est:71.10
    Beta:0.472623
    Next Earnings Date:N/A
    Day's Range:55.16 - 56.25
    52wk Range:41.72 - 60.34
    Volume:587,920
    Avg Vol (3m):1,356,920
    Market Cap:142.56B
    P/E (ttm):30.37
    EPS (ttm):1.82
    Div & Yield:0.73 (1.30%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVODown 0.78%142.56B
    LLYDown 0.66%87.52B
    PFEDown 1.67%198.07B

    Key Statistics

    Forward P/E (1 yr):27.38
    P/S (ttm):9.55
    Ex-Dividend Date:19-Mar-15

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback